Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

22

Revenue 2017

Januvia

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Januvia was produced by Merck & Co..

Pharma deals during April 2013

Pharma deals during April 2013 standalone product and in combination with other drugs, including Januvia (Merck's blockbuster DPP-4 inhibitor) and metformin. ... Januvia franchise, Pfizer gets to piggyback on Merck's diabetes franchise and part funding of the phase III trial.

Merck & Co enters $430m diabetes deal with Abide

Merck & Co enters $430m diabetes deal with Abide One of the key reason for the Pfizer deal is the potential to combine ertugliflozin with Merck's DPP-4 inhibitor Januvia (sitagliptin). ... Merck also has a Januvia follow-up in development, with phase IIb data suggesting that MK-3102 could offer a

Merck cuts outlook as Q1 sales fall

Merck cuts outlook as Q1 sales fall More worryingly, Merck's Januvia (sitagliptin) product franchise failed to live up to expectations, with sales down 4 per cent to $884m mainly resulting from lower turnover in the US, according ... on a conference call, while insisting that growth

Merck & Co and Pfizer join forces on diabetes candidate

Merck & Co and Pfizer join forces on diabetes candidate s DPP-4 inhibitor Januvia (sitagliptin).

Merck & Co fails to block generic Januvia in India

Merck & Co fails to block generic Januvia in India Glenmark Pharmaceuticals from selling a generic version of its Januvia and Janumet diabetes drugs. ... The US pharma giant filed a lawsuit against Glenmark earlier this month after the Indian drugmaker started selling copycat versions of Januvia

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...